RT Journal Article
T1 Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement.
A1 Saibene, Alberto Maria
A1 Allevi, Fabiana
A1 Ayad, Tareck
A1 Baudoin, Tomislav
A1 Bernal-Sprekelsen, Manuel
A1 Briganti, Giovanni
A1 Carrie, Sean
A1 Cayé-Thomasen, Per
A1 Dahman Saidi, Sara
A1 Dauby, Nicolas
A1 Fenton, John
A1 Golusiński, Wojciech
A1 Klimek, Ludger
A1 Leclerc, Andrée-Anne
A1 Longtin, Yves
A1 Mannelli, Giuditta
A1 Mayo-Yáñez, Miguel
A1 Meço, Cem
A1 Metwaly, Osama
A1 Mouawad, François
A1 Niemczyk, Kazimierz
A1 Pedersen, Ulrik
A1 Piersiala, Krzysztof
A1 Plzak, Jan
A1 Remacle, Marc
A1 Rommel, Nathalie
A1 Saleh, Hesham
A1 Szpecht, Dawid
A1 Tedla, Miroslav
A1 Tincati, Camilla
A1 Tucciarone, Manuel
A1 Zelenik, Karol
A1 Lechien, Jerome R
K1 Breastfeeding
K1 Coronavirus infections
K1 Covid-19
K1 Health planning guidelines
K1 Healthcare workers
K1 Pregnancy
K1 Vaccine
AB SARS-CoV-2 vaccines are a key step in fighting the pandemic. Nevertheless, their rapid development did not allow for testing among specific population subgroups such as pregnant and breastfeeding women, or elaborating specific guidelines for healthcare personnel working in high infection risk specialties, such as otolaryngology (ORL). This clinical consensus statement (CCS) aims to offer guidance for SARS-CoV-2 vaccination to this high-risk population based on the best evidence available. A multidisciplinary international panel of 33 specialists judged statements through a two-round modified Delphi method survey. Statements were designed to encompass the following topics: risk of SARS-Cov-2 infection and use of protective equipment in ORL; SARS-Cov-2 infection and vaccines and respective risks for the mother/child dyad; and counseling for SARS-CoV-2 vaccination in pregnant, breastfeeding, or fertile healthcare workers (PBFHW). All ORL PBFHW were considered as the target audience. Of the 13 statements, 7 reached consensus or strong consensus, 2 reached no consensus, and 2 reached near-consensus. According to the statements with strong consensus otorhinolaryngologists-head and neck surgeons who are pregnant, breastfeeding, or with childbearing potential should have the opportunity to receive SARS-Cov-2 vaccination. Moreover, personal protective equipment (PPE) should still be used even after the vaccination. Until prospective evaluations on these topics are available, ORL-HNS must be considered a high infection risk specialty. While the use of PPE remains pivotal, ORL PBFHW should be allowed access to SARS-CoV-2 vaccination provided they receive up-to-date information.
YR 2021
FD 2021-04-15
LK http://hdl.handle.net/10668/17581
UL http://hdl.handle.net/10668/17581
LA en
DS RISalud
RD Apr 9, 2025